Key Statistics for 2183
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (03/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 2183
- Net Income (M/JPY)
LINICAL CO LTD is a Contract Research Organization (CRO) for Pharmaceutical Companies. The company specializes in Clinical Research Associate of Phase II and Phase III, while conducting other clinical trial related services such as Quality Management and Consulting.
More Company Profile & Key Executives for 2183
|Keigo TsujimotoExecutive Vice President||Akihiro TakahashiSenior Managing Director/CFO|
|Jun KawaiSenior Managing Director||Yoshio KajiManaging Director|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.